These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7508330

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunohistochemical detection of beta-human chorionic gonadotropin in urothelial carcinoma.
    Ozkardeş H, Ergen A, Ozen HA, Ayhan A, Remzi D.
    Int Urol Nephrol; 1991; 23(1):5-11. PubMed ID: 1718919
    [Abstract] [Full Text] [Related]

  • 3. The expression of beta human chorionic gonadotrophin (β-HCG) in human urothelial carcinoma.
    Venyo AK, Herring D, Greenwood H, Maloney DJ.
    Pan Afr Med J; 2010; 7():20. PubMed ID: 21918707
    [Abstract] [Full Text] [Related]

  • 4. Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder.
    Martin JE, Jenkins BJ, Zuk RJ, Oliver RT, Baithun SI.
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(3):273-7. PubMed ID: 2494806
    [Abstract] [Full Text] [Related]

  • 5. Expression of beta-human chorionic gonadotropin (beta-hCG) in non-trophoblastic elements of transitional cell carcinoma of the bladder: possible relationship with the prognosis.
    Bacchi CE, Coelho KI, Goldberg J.
    Rev Paul Med; 1993; 111(3):412-6. PubMed ID: 8108635
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prediction of response to radiotherapy in invasive bladder cancer.
    Jenkins BJ, Martin JE, Baithun SI, Zuk RJ, Oliver RT, Blandy JP.
    Br J Urol; 1990 Apr; 65(4):345-8. PubMed ID: 2340369
    [Abstract] [Full Text] [Related]

  • 8. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer.
    Iles RK, Persad R, Trivedi M, Sharma KB, Dickinson A, Smith P, Chard T.
    Br J Urol; 1996 Jan; 77(1):61-9. PubMed ID: 8653319
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Qualitative analysis of the immunoreactive hCG beta-like substance produced by transitional cell carcinoma of the bladder].
    Yamanaka N, Nishimura R.
    Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1150-6. PubMed ID: 1716709
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum and urinary levels of beta human chorionic gonadotrophin in patients with transitional cell carcinoma.
    McLoughlin J, Pepera T, Bridger J, Williams G.
    Br J Cancer; 1991 May; 63(5):822-4. PubMed ID: 1710137
    [Abstract] [Full Text] [Related]

  • 18. [Urinary bladder transitional cell carcinoma with trophoblastic differentiation].
    Moldavsky M, Sazbon A, Kuchersky N, Turani H.
    Harefuah; 1997 Apr 01; 132(7):452-4, 528. PubMed ID: 9153909
    [Abstract] [Full Text] [Related]

  • 19. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
    Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM, Lerner SP.
    J Urol; 2001 May 01; 165(5):1473-9. PubMed ID: 11342899
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.